Search results for "PROGRESS"

showing 10 items of 1620 documents

OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes.

2016

Background: The identification of biomarkers for the estimation of cancer patients’ survival is a crucial problem in modern oncology. Recently, the Affymetrix DMET (Drug Metabolizing Enzymes and Transporters) microarray platform has offered the possibility to determine the ADME (absorption, distribution, metabolism, and excretion) gene variants of a patient and to correlate them with drug-dependent adverse events. Therefore, the analysis of survival distribution of patients starting from their profile obtained using DMET data may reveal important information to clinicians about possible correlations among drug response, survival rate, and gene variants. Methods: In order to provide support …

0301 basic medicinepharmacogenomicoverall survivalBiomedical EngineeringDME genes; genotyping microarrays; overall survival; pharmacogenomics; progression-free survivalBioengineeringBiologyBioinformaticsBiochemistryArticlelcsh:Biochemistrygenotyping microarray03 medical and health sciencesmedicineOverall survivallcsh:QD415-436Progression-free survivalgenotyping microarraysAdverse effectSurvival rateGeneADMEpharmacogenomicsADME geneCancermedicine.diseaseADME genesgenotyping microarrays; ADME genes; pharmacogenomics; overall survival; progression-free survival030104 developmental biologyPharmacogenomicsprogression-free survivalBiotechnologyMicroarrays (Basel, Switzerland)
researchProduct

European contribution to the study of ROS : A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

2017

WOS: 000410470000009

0301 basic medicinereactive oxygen species ; reactive nitrogen species ; redox signaling ; oxidative stress ; antioxidants ; redox therapeuticsRedox signalingInternational CooperationSMOOTH-MUSCLE-CELLS[SDV]Life Sciences [q-bio]Clinical BiochemistryISCHEMIA-REPERFUSION INJURYReviewddc:616.07Bioinformaticsmedicine.disease_causeBiochemistryAntioxidants0302 clinical medicineENDOPLASMIC-RETICULUM STRESSCost actionlcsh:QH301-705.5ComputingMilieux_MISCELLANEOUSmedia_commonlcsh:R5-920Redox therapeuticsReactive nitrogen species3. Good healthVariety (cybernetics)MANGANESE SUPEROXIDE-DISMUTASECHRONIC GRANULOMATOUS-DISEASERisk analysis (engineering)ddc:540lcsh:Medicine (General)Oxidation-ReductionSignal TransductionSocieties ScientificPULMONARY ARTERIAL-HYPERTENSIONMedicinaEstrès oxidatiuBiology03 medical and health sciencesAntioxidants ; Oxidative Stress ; Reactive Nitrogen Species ; Reactive Oxygen Species ; Redox Signaling ; Redox TherapeuticsJournal Articlemedicinemedia_common.cataloged_instanceAnimalsHumans[CHIM]Chemical SciencesEuropean UnionEuropean unionNITRIC-OXIDE SYNTHASETANDEM MASS-SPECTROMETRYMolecular BiologyMITOCHONDRIAL OXIDATIVE STRESSGROWTH-FACTOR-BETAOrganic ChemistryDisease progressionBiology and Life SciencesOxidation reductionManganese Superoxide Dismutase030104 developmental biologylcsh:Biology (General)Oxidative stressReactive oxygen species030217 neurology & neurosurgeryOxidative stressRedox biology
researchProduct

Modulating disease-relevant tau oligomeric strains by small molecules

2020

The pathological aggregation of tau plays an important role in Alzheimer's disease and many other related neurodegenerative diseases, collectively referred to as tauopathies. Recent evidence has demonstrated that tau oligomers, small and soluble prefibrillar aggregates, are highly toxic due to their strong ability to seed tau misfolding and propagate the pathology seen across different neurodegenerative diseases. We previously showed that novel curcumin derivatives affect preformed tau oligomer aggregation pathways by promoting the formation of more aggregated and nontoxic tau aggregates. To further investigate their therapeutic potential, we have extended our studies o disease-relevant bra…

0301 basic medicinetau oligomeric strainsCurcuminTau proteinsmall moleculetau ProteinsProtein aggregationBiochemistrytau proteinoligomerProgressive supranuclear palsyprotein aggregationDiagnosis DifferentialSmall Molecule Libraries03 medical and health scienceschemistry.chemical_compoundBiopolymersmental disordersmedicineHumansMolecular BiologyCells CulturedNeurons030102 biochemistry & molecular biologybiologyChemistryDementia with Lewy bodiesbrain-derived tau oligomerstau aggregationtauopathytoxicityBrainMolecular Bases of DiseaseCell Biologymedicine.diseaseSmall moleculeImaging agentCell biology030104 developmental biologyTauopathiesbiology.proteinCurcuminTauopathyThe Journal of Biological Chemistry
researchProduct

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial T…

2019

Background: In patients with differentiated thyroid cancer (DTC) and raising serum thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an empiric 131I therapy may be considered. However, outcome data after empiric therapy in did not show a clear evidence of improved survival. We assessed the efficacy of such empiric 131I therapy in patients with DTC and evaluated the long-term outcome.Methods: A total of 100 patients with DTC showing raised Tg level during follow-up after thyroidectomy and 131I ablation were treated with a further 131I therapy (6.1 ± 1.7 GBq). Whole-body scan (WBS) was performed 5–7 days after therapy. Tg value at 12 months after 131I therap…

0301 basic medicinewhole body scanmedicine.medical_specialtymedicine.medical_treatmentEndocrinology Diabetes and Metabolismchemistry.chemical_element030209 endocrinology & metabolismIodinethyroglobulinlcsh:Diseases of the endocrine glands. Clinical endocrinologyGastroenterology03 medical and health sciences0302 clinical medicineStable DiseaseEndocrinologyInternal medicinemedicineInitial treatmentProgression-free survivalThyroid cancerdifferentiated thyroid carcinomaOriginal Researchlcsh:RC648-665business.industry131I empiric therapyThyroidectomymedicine.disease030104 developmental biologychemistryThyroglobulinprognosisbusinessdifferentiated thyroid carcinoma 131I empiric therapy prognosis thyroglobulin whole body scanEmpiric therapyFrontiers in endocrinology
researchProduct

The Impact of Body Mass Index on Disease Progression in Ankylosing Spondylitis

2018

Abstract Obesity can be a factor that affects the course of chronic systemic inflammatory arthritis. The objective of this study was to characterise patients with ankylosing spondylitis (AS) according to an evaluation of their body mass index (BMI) and by exploring the link between the overweightness and obesity with routinely measured disease-specific variables, including disease activity (Bath Ankylosing Spondylitis Disease Activity Index BASDAI; Ankylosing Spondylitis Disease Activity Score, using CRP, ASDAScrp), spinal mobility (Bath Ankylosing Spondylitis Metrology Index, BASMI), functional capacity (BASFI), extraspinal manifestations like fatigue, uveitis, and peripheral arthritis pre…

030203 arthritis & rheumatologymedicine.medical_specialtyAnkylosing spondylitisobesityMultidisciplinaryGeneral interestfunctional disabilityScienceDisease progressionQnutritional and metabolic diseasesbody mass indexmedicine.disease03 medical and health sciences0302 clinical medicineInternal medicineankylosing spondylitismedicineoverweight030212 general & internal medicineBody mass indexdisease activityProceedings of the Latvian Academy of Sciences. Section B, Natural Sciences
researchProduct

Advanced mechanotherapy: Biotensegrity  for governing metastatic tumor cell fate via modulating the extracellular matrix.

2021

Mechano-transduction is the procedure of mechanical stimulus translation via cells, among substrate shear flow, topography, and stiffness into a biochemical answer. TAZ and YAP are transcriptional coactivators which are recognized as relay proteins that promote mechano-transduction within the Hippo pathway. With regard to healthy cells in homeostasis, mechano-transduction regularly restricts proliferation, and TAZ and YAP are totally inactive. During cancer development a YAP/TAZ - stimulating positive response loop is formed between the growing tumor and the stiffening ECM. As tumor developments, local stromal and cancerous cells take advantage of mechanotransduction to enhance proliferatio…

0303 health sciencesHippo signaling pathwayStromal cellChemistryPharmaceutical ScienceCell Differentiation02 engineering and technologyCell fate determination021001 nanoscience & nanotechnologyPhosphoproteinsMechanotransduction CellularCell biologyExtracellular MatrixExtracellular matrix03 medical and health sciencesMechanobiologyTumor progressionNeoplasmsHumansMechanotransduction0210 nano-technologyMechanotherapy030304 developmental biologyAdaptor Proteins Signal TransducingJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Do typically and atypically developing children learn and generalize novel names similarly: The role of conceptual distance during learning and at te…

2020

International audience; There is a large body of evidence showing that comparison of multiple stimuli leads to better conceptualization and generalization of novel names than no-comparison settings in typically developing (TD) children. By contrast, the evidence regarding this issue remains scarce in children with intellectual disabilities (ID). Children with intellectual disabilities (ID) and TD children matched on mental age with the Raven's coloured progressive matrices were tested in several novel name learning comparison conditions, with familiar objects. We manipulated the conceptual distance between the learning stimuli in the learning phase and between the learning and generalizatio…

030506 rehabilitationIntellectual disabilities03 medical and health sciencesRaven's Progressive MatricesCognitionComparisonsGeneralization (learning)Intellectual DisabilityIntellectual disabilityDevelopmental and Educational PsychologymedicineHumansLearningNames0501 psychology and cognitive sciencesCognitive skill10. No inequalityChildMental ageIntelligence TestsConceptualization4. Education05 social sciencesmedicine.diseaseObject and relational categoriesClinical PsychologyLanguage developmentCategorization[SCCO.PSYC]Cognitive science/Psychology0305 other medical sciencePsychologyConceptual distance050104 developmental & child psychologyCognitive psychologyResearch in developmental disabilities
researchProduct

Assessment of Functional Activities in Individuals with Parkinson’s Disease Using a Simple and Reliable Smartphone-Based Procedure

2020

Parkinson&rsquo

030506 rehabilitationmedicine.medical_specialtyParkinson's diseaseFunctional impairmentHealth Toxicology and MutagenesisParkinson's diseasefunctional mobilitylcsh:Medicinesmartphonegaitpostural controlArticlePostural control03 medical and health sciences0302 clinical medicineGait (human)Physical medicine and rehabilitationmedicineHumansPostural BalanceGaitGait Disorders NeurologicBalance (ability)Monitoring Physiologicbusiness.industryinertial measurement unitParkinson’s disease functional mobility gait inertial measurement unit postural control smartphonelcsh:RPublic Health Environmental and Occupational HealthPostural controlParkinson DiseaseProgressive neurodegenerative disordermedicine.diseasenervous system diseasesInertial measurement unitFunctional mobilityParkinson’s diseaseFunctional activitySmartphone0305 other medical sciencebusiness030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

Anti-Semitism and Progressive Era Social Science. The case of John R. Commons

2016

This paper explores Common’s views toward Jews in order to assess whether his published writings contain assertion that today would be stigmatized as anti-Semitic. The evidence we provide shows that Commons’ racial characterization of Jews was framed within a broad and indiscriminate xenophobic framework. With other leading Progressive Era social scientists, in fact, Commons shared the idea that the new immigration from Eastern and southern Europe would increase competition in the labor market, drive down wages, and lead Anglo-Saxon men and women to have fewer children, since they would not want them to compete with those who survive on less. Within this general xenophobic context, Commons …

060106 history of social sciencesmedia_common.quotation_subjectImmigrationContext (language use)Competition (economics)Progressivism Anti-semitismHistory and Philosophy of ScienceOrder (exchange)0502 economics and businessEconomics0601 history and archaeology050207 economicsSocial scienceSettore SECS-P/04 - STORIA DEL PENSIERO ECONOMICOmedia_commonCommons J. RPovertyGeneral Arts and Humanities05 social sciencesCommons john RCommons John Roger; Anti-Semitism; Race; ImmigrationAnti-Semitism06 humanities and the artsjel:B15MercantilismPolitical economyUnemploymentjel:B1CommonsGeneral Economics Econometrics and Finance
researchProduct

Vitamin D and Parkinson's Disease.

2022

Vitamin D is a fat-soluble secosteroid, traditionally considered a key regulator of bone metabolism, calcium and phosphorous homeostasis. Its action is made possible through the binding to the vitamin D receptor (VDR), after which it directly and indirectly modulates the expression of thousands of genes. Vitamin D is important for brain development, mature brain activity and associated with many neurological diseases, including Parkinson’s disease (PD). High frequency of vitamin D deficiency in patients with Parkinson’s disease compared to control population was noted nearly twenty years ago. This finding is of interest given vitamin D’s neuroprotective effect, exerted by the action of neur…

125-dihydroxyvitamin DDisease progressionNutrition and DieteticsParkinson DiseaseVitaminsVitamin D DeficiencyNeuroprotectionCalcium DietaryParkinson’s diseaseHumansSettore MED/26 - NeurologiaNeurodegenerationVitamin DHumanFood ScienceNutrients
researchProduct